3-nitrobenzothiazolo(3,2-a)quinolinium has been researched along with fagaronine in 1 studies
| Studies (3-nitrobenzothiazolo(3,2-a)quinolinium) | Trials (3-nitrobenzothiazolo(3,2-a)quinolinium) | Recent Studies (post-2010) (3-nitrobenzothiazolo(3,2-a)quinolinium) | Studies (fagaronine) | Trials (fagaronine) | Recent Studies (post-2010) (fagaronine) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 39 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Báez, A; Torres, CA | 1 |
1 other study(ies) available for 3-nitrobenzothiazolo(3,2-a)quinolinium and fagaronine
| Article | Year |
|---|---|
Effects of the antitumor drugs 3-nitrobenzothiazolo[3,2-alpha]quinolinium and fagaronine on nucleic acid and protein synthesis.
Topics: Alkaloids; Animals; Antineoplastic Agents; Benzophenanthridines; Carcinoma, Ehrlich Tumor; Cell-Free System; DNA Polymerase I; DNA-Directed RNA Polymerases; DNA, Neoplasm; Escherichia coli; Humans; KB Cells; Mice; Neoplasm Proteins; Neoplasms, Experimental; Phenanthridines; Protein Biosynthesis; Quinolinium Compounds; RNA, Neoplasm | 1986 |